Özlem CEMEROĞLU, Zeynep Sıla YAŞAR, Mustafa SAĞLAM, Haşim ÇAKIRBAY

Clinical and demographic findings of patients with rheumatoid arthritis and ankylosing spondylitis treated in a tertiary care center in Turkey

Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are 2 common rheumatic diseases that are frequent causes of disability. In this descriptive study, demographic, clinical, and laboratory findings of patients with RA and AS being followed in a tertiary care center in Turkey were reported. Materials and methods: The patient data of 45 RA and 45 AS cases were collected retrospectively from electronic medical records. Demographic findings, clinical and laboratory assessments of disease activity, drugs used for the treatment, and effect on quality of life of patients with RA and AS were analyzed. Results: In RA patients, 27% had mild, 44% had moderate, and 29% had severe disease and 25% of the patients had satisfactory functional state. In AS patients, the mean Bath Ankylosing Spondylitis Disease Activity Index score was 4.6 ± 2.3 and 64% had active disease. Sixteen percent of the patients with AS reported satisfactory functional state. In RA cases, the highest percentage of patients were treated with biological agents. In AS cases, 24% of patients were treated with NSAIDs and 22% received biological agents. Conclusion: In our tertiary care center, the majority of patients with RA and AS had active disease with unsatisfactory functional states.

Anahtar Kelimeler:

Key words: Rheumatoid arthritis, ankylosing spondylitis, demographics

Clinical and demographic findings of patients with rheumatoid arthritis and ankylosing spondylitis treated in a tertiary care center in Turkey

Keywords:

Key words: Rheumatoid arthritis, ankylosing spondylitis, demographics,

PDF

___

Senerdem N, Gül A, Koniçe M, Aral O, Ocal L, Inanç M,
Yüzbaşioğlu N. The use of two different Health Assessment
Questionnaires in Turkish rheumatoid arthritis population and
assessment of the associations with disability. Clin Rheumatol 1999; 18: 33–37. 7.
Kutlay S, Kucukdeveci AA, Gonul D, Tennant A. Adaptation
and validation of the Turkish version of the Rheumatoid
Arthritis Quality of Life Scale. Rheumatol Int 2003; 23: 21–26. 8.
Sany J, Bourgeois P, Saraux A, Durieux S, Lafuma A, Daurès
JP, Guillemin F, Sibilia J. Characteristics of patients with
rheumatoid arthritis in France: a study of 1109 patients
managed by hospital based rheumatologists. Ann Rheum Dis 2004; 63: 1235–1240. 9.
Braun J, Davis J, Dougados M, Sieper J, van der Linden S,
van der Heijde D; ASAS Working Group. First update of the
international ASAS consensus statement for the use of anti
TNF agents in patients with ankylosing spondylitis. Ann
Rheum Dis 2006; 65: 316–320.
van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361–368.
Yanik B, Gürsel YK, Kutlay S, Ay S, Elhan AH. Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS. Clin Rheumatol 2005; 24: 41–47.
Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N. A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 2005; 25: 280–284.
Ozer HT, Sarpel T, Gulek B, Alparslan ZN, Erken E. Evaluation of the Turkish version of the Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Clin Rheumatol 2006; 25: 136– 139.
Ozcan E, Yilmaz O, Tutoglu A, Bodur H. Validity and reliability of the Turkish version of the Health Assessment Questionnaire for the Spondyloarthropathies. Rheumatol Int 2012; 32: 1563– 1568.
Bodur H, Ataman S, Rezvani A, Buğdaycı DS, Cevik R, Birtane M, Akıncı A, Altay Z, Günaydın R, Yener M et al. Quality of life and related variables in patients with ankylosing spondylitis. Qual Life Res 2011; 20: 543–549.
Kaçar C, Gilgil E, Tuncer T, Bütün B, Urhan S, Arikan V, Dündar U, Oksüz MC, Sünbüloğlu G, Yildirim C et al. Prevalence of rheumatoid arthritis in Antalya, Turkey. Clin Rheumatol 2005; 24: 212–214.
Calgüneri M, Ureten K, Akif Oztürk M, Onat AM, Ertenli I, Kiraz S, Akdogan A. Extra-articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey. Clin Exp Rheumato 2006; 24: 305–308.
Onen F, Akar S, Birlik M, Sari I, Khan MA, Gurler O, Ergor A, Manisali M, Akkoc N. Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of Izmir, Turkey. J Rheumatol 2008; 35: 305–309.
Bodur H, Ataman S, Akbulut L, Evcik D, Kavuncu V, Kaya T, Günaydin R, Kuran B, Kotevoğlu N, Bal A et al. Characteristics and medical management of patients with rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol 2008; 27: 1119– 1125.
Aleta D, Smolen JS. The rheumatoid arthritis patient in the clinic: comparing more than 1300 consecutive DMARD courses. Rheumatology 2002; 41: 1367–1374.
Akkoc N, van der Linden S, Khan MA. Ankylosing spondylitis and symptom-modifying vs. disease-modifying therapy. Best Pract Res Clin Rheumatol 2006; 20: 539–557.